Multicenter nit‐occlud® PDA‐R patent. Ductus arteriosus occlusion device trial: Initial and six‐month results

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|86|2|258-263

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.86, Iss.2, 2015-08, pp. : 258-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Initial experience with the novel patent foramen ovale occlusion device Nit‐Occlud® in patients with stroke or transient ischemic attack

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 7, 2015-06 ,pp. : 1262-1267

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implantation of the new Nit‐Occlud PDA‐R device in children below 10 kilogram

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 7, 2015-06 ,pp. : 1203-1208

John Wiley & Sons Inc

Access to resources Recommend Favorite

Techniques for trans‐catheter retrieval of embolized Nit‐Occlud® PDA‐R and ASD‐R devices

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 3, 2018-02 ,pp. : 478-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: Relationship between PDA type and risk of device protrusion into the descending aorta

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : E66-E72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trans‐pulmonary echocardiography as a guide for device closure of patent ductus arteriosus

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 264-270

John Wiley & Sons Inc

Access to resources Recommend Favorite